Dec 3, 2018   SOURCE: PR NewsWire

BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City

SAN RAFAEL, Calif., Dec. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.


     Contacts:



     Investors                              
     Media



     
             Traci McCarty                
     
         Debra Charlesworth



     
             BioMarin Pharmaceutical Inc.         BioMarin Pharmaceutical Inc.



     
             (415) 455-7558               
     
         (415) 455-7451

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-citis-13th-annual-biotech-conference-on-december-5-in-new-york-city-300758812.html

SOURCE BioMarin Pharmaceutical Inc.